Raltegravir-Isentress, An Important Antiretroviral in HIV/AIDS Treatment


Raltegravir-Isentress, An Important Antiretroviral in HIV/AIDS Treatment

This is an automatically generated default intro template – please do not edit.


General information


Title: Raltegravir-Isentress, An Important Antiretroviral in HIV/AIDS Treatment
Meta keywords:
Meta description:

Images information


Images path absolute: /home/jmedarr/public_html/images/stories/com_form2content/p2/f261
Images path relative: com_form2content/p2/f261
Thumbs path absolute:
Thumbs path relative:

Fields information


Article_Title: Raltegravir-Isentress, An Important Antiretroviral in HIV/AIDS Treatment
Authors: Conf.Dr.Mirandolina Prisca, S.L Dr.Gheorghe Nini
Affiliation: “Vasile Goldis” Western University of Arad
Abstract: Even though there were registered major progresses in HAART therapy (Highly Active Antiretroviral Therapy) – complex of several ARVs (antiretroviral) used together – the HIV infection still remains an important problem with more than 33 milion patiens all over the world and a global incidence of 2.6 milion new infections discovered every year.
Starting with 2007 there is rumour around a brand new drug therapy for the HIV, the integrase inhibitors.
Keywords:
References:
Read_full_article: pdf/vol16/iss1-4/5 JMA 2013 Prisca – Raltegravir articol revista uvvgzz.pdf
Correspondence:

Read full article
Article Title: Raltegravir-Isentress, An Important Antiretroviral in HIV/AIDS Treatment
Authors: Conf.Dr.Mirandolina Prisca, S.L Dr.Gheorghe Nini
Affiliation: “Vasile Goldis” Western University of Arad
Abstract: Even though there were registered major progresses in HAART therapy (Highly Active Antiretroviral Therapy) – complex of several ARVs (antiretroviral) used together – the HIV infection still remains an important problem with more than 33 milion patiens all over the world and a global incidence of 2.6 milion new infections discovered every year.
Starting with 2007 there is rumour around a brand new drug therapy for the HIV, the integrase inhibitors.
Keywords:
References:
*Correspondence: